About the Authors
- Ruchi Bansal
-
* E-mail: R.Bansal@utwente.nl
Affiliations Department of Controlled Drug Delivery (Targeted Therapeutics), MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands, Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Jai Prakash
-
Affiliations Department of Controlled Drug Delivery (Targeted Therapeutics), MIRA Institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, The Netherlands, Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Marieke De Ruiter
-
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
- Klaas Poelstra
-
Affiliation Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen, Groningen, The Netherlands
Competing Interests
KP is scientific advisor and shareholder of BiOrion Technologies B.V., a company dedicated to the commercialization of drug carriers, including the carrier presented here. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: RB JP KP. Performed the experiments: RB MDR. Analyzed the data: RB JP. Wrote the paper: RB JP KP.